data_1iij_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iij _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.582 2.205 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -60.91 -37.1 79.83 Favored 'Trans proline' 0 CA--C 1.569 2.23 0 CA-C-N 125.08 2.85 . . . . 0.0 117.601 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.9 -44.98 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-N 119.903 1.229 . . . . 0.0 113.949 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.2 m -58.29 -44.62 88.59 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -56.58 -43.93 80.51 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 167.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.1 mt -60.43 -47.26 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 119.916 1.234 . . . . 0.0 113.484 169.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.9 mt -56.13 -52.87 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 119.657 1.117 . . . . 0.0 113.594 171.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.28 74.35 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 168.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.5 m -63.33 -50.35 70.33 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.2 p -60.86 -42.95 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 175.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.266 30.0 m -64.89 -41.96 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 169.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.45 -46.98 92.36 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 118.238 2.055 . . . . 0.0 118.238 168.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.9 t -60.57 -46.68 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 168.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.0 tp -56.85 -47.95 79.2 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 170.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.4 mt -59.05 -42.31 89.97 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -60.2 -50.6 73.04 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.292 2.5 pp -62.62 -37.94 88.27 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 174.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.9 mt . . . . . 0 N--CA 1.5 2.046 0 CA-C-N 119.694 1.134 . . . . 0.0 111.969 172.529 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 CA--C 1.58 2.1 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.05 -32.7 27.41 Favored 'Trans proline' 0 CA--C 1.568 2.217 0 CA-C-N 125.075 2.848 . . . . 0.0 117.904 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.35 -43.56 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 CA-C-N 120.781 1.628 . . . . 0.0 113.383 166.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.2 m -56.98 -43.96 82.22 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 167.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -57.68 -43.7 85.28 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 166.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.7 mt -59.91 -47.03 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 120.113 1.324 . . . . 0.0 113.543 169.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -56.15 -53.24 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 119.643 1.111 . . . . 0.0 113.489 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.32 -39.97 73.63 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 117.842 2.534 . . . . 0.0 117.842 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.7 m -63.45 -50.24 70.49 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 173.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.286 8.6 p -60.92 -43.51 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.267 29.9 m -64.63 -42.08 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 169.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.28 -47.27 89.1 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 168.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.67 -48.13 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-N 118.493 1.146 . . . . 0.0 113.836 168.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 27.6 tp -53.99 -47.4 71.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.9 mt -60.75 -41.86 96.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 166.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -62.62 -55.11 30.08 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.355 1.0 OUTLIER -64.28 -40.56 96.2 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 177.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.5 mt . . . . . 0 N--CA 1.5 2.058 0 CA-C-N 119.462 1.028 . . . . 0.0 112.232 176.427 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 t . . . . . 0 CA--C 1.576 1.969 0 CA-C-O 116.123 -1.894 . . . . 0.0 108.481 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -64.93 -43.39 12.11 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 CA-C-N 124.968 2.81 . . . . 0.0 117.03 169.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.84 -43.31 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-N 119.872 1.214 . . . . 0.0 113.406 171.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.7 m -57.34 -46.43 83.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 167.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -55.71 -47.79 76.27 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 168.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.21 -42.55 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 120.067 1.303 . . . . 0.0 114.163 174.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.1 -52.0 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 120.183 1.356 . . . . 0.0 113.306 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.11 72.5 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 168.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.5 m -63.14 -50.33 70.86 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.6 p -61.11 -43.29 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.267 30.5 m -64.77 -41.82 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 169.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.55 -47.17 91.47 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 168.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.58 -46.63 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 118.527 1.163 . . . . 0.0 114.003 168.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.92 -49.16 77.7 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 171.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.5 mt -60.44 -36.22 77.69 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.396 1.998 . . . . 0.0 116.396 167.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -60.41 -56.55 20.11 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 167.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.268 3.1 pp -63.21 -34.79 78.41 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 N--CA 1.501 2.085 0 CA-C-N 119.664 1.12 . . . . 0.0 112.191 172.42 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.6 t . . . . . 0 CA--C 1.579 2.073 0 N-CA-C 117.361 2.356 . . . . 0.0 117.361 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.57 -33.16 29.46 Favored 'Trans proline' 0 CA--C 1.57 2.293 0 CA-C-N 125.437 2.977 . . . . 0.0 117.35 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.53 -45.56 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 120.323 1.419 . . . . 0.0 113.496 165.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 m -56.55 -44.78 81.26 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 168.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -57.44 -43.88 84.27 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 166.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.2 mt -59.94 -46.93 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 CA-C-N 120.078 1.308 . . . . 0.0 113.485 170.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.5 mt -56.16 -52.85 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-N 119.664 1.12 . . . . 0.0 113.548 171.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.26 76.24 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 169.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.9 m -63.68 -50.06 70.71 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 7.6 p -60.49 -42.97 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 175.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.268 31.1 m -64.34 -42.32 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 169.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.01 -46.9 90.97 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 167.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.5 t -60.28 -48.5 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 118.388 1.094 . . . . 0.0 113.851 168.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 tp -54.04 -47.95 71.04 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.5 mt -59.76 -40.51 88.42 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 166.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.8 -57.59 9.44 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.337 1.0 OUTLIER -64.65 -38.63 91.67 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.3 mt . . . . . 0 N--CA 1.498 1.94 0 CA-C-N 119.319 0.963 . . . . 0.0 111.783 175.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.6 t . . . . . 0 CA--C 1.583 2.214 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -61.81 -38.18 61.57 Favored 'Trans proline' 0 CA--C 1.57 2.292 0 CA-C-N 125.318 2.935 . . . . 0.0 117.325 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.76 -45.29 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 119.863 1.21 . . . . 0.0 113.883 168.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.3 m -57.7 -44.49 85.92 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 168.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.06 -43.84 82.44 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 167.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.8 mt -60.32 -47.04 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-N 119.985 1.266 . . . . 0.0 113.503 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -56.13 -52.92 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 119.669 1.122 . . . . 0.0 113.533 171.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.6 -40.24 74.96 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 169.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.4 m -63.35 -50.26 70.68 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 173.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.3 p -60.72 -43.31 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.268 30.3 m -64.54 -42.21 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 169.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.32 -46.94 91.24 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 118.289 2.076 . . . . 0.0 118.289 168.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.34 -48.23 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 118.477 1.139 . . . . 0.0 113.809 168.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.4 tp -54.27 -48.0 71.68 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 171.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.7 mt -59.97 -40.58 89.59 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 166.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -63.17 -57.92 8.92 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.339 1.0 OUTLIER -64.51 -38.42 90.94 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.498 1.971 0 CA-C-N 119.365 0.984 . . . . 0.0 111.874 175.858 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . 0.257 13.0 pt-20 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -62.0 -50.5 71.82 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -79.38 -40.0 31.2 Favored 'General case' 0 CA--C 1.574 1.877 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 165.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.02 92.44 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 118.268 2.692 . . . . 0.0 118.268 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -61.31 -56.55 32.86 Favored Pre-proline 0 CA--C 1.582 2.205 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 171.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -60.91 -37.1 79.83 Favored 'Trans proline' 0 CA--C 1.569 2.23 0 CA-C-N 125.08 2.85 . . . . 0.0 117.601 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.9 -44.98 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-N 119.903 1.229 . . . . 0.0 113.949 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.2 m -58.29 -44.62 88.59 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -56.58 -43.93 80.51 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 167.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.1 mt -60.43 -47.26 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 119.916 1.234 . . . . 0.0 113.484 169.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.9 mt -56.13 -52.87 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 119.657 1.117 . . . . 0.0 113.594 171.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.28 74.35 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 168.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.5 m -63.33 -50.35 70.33 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.2 p -60.86 -42.95 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 175.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.266 30.0 m -64.89 -41.96 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 169.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.45 -46.98 92.36 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 118.238 2.055 . . . . 0.0 118.238 168.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.9 t -60.57 -46.68 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 168.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.0 tp -56.85 -47.95 79.2 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 170.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.4 mt -59.05 -42.31 89.97 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -60.2 -50.6 73.04 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.292 2.5 pp -62.62 -37.94 88.27 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 174.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.9 mt -72.79 -60.61 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.694 1.134 . . . . 0.0 111.969 172.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 76.7 mt -78.9 -44.18 23.3 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -171.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.4 t -82.82 -54.81 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 119.553 1.07 . . . . 0.0 112.102 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.0 t -72.88 -56.74 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 120.773 -1.205 . . . . 0.0 113.28 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.254 90.0 t -71.75 -67.42 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-N 120.778 1.626 . . . . 0.0 112.446 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.295 29.3 m -85.11 58.35 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-N 120.964 1.711 . . . . 0.0 114.109 176.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -172.07 -78.79 0.05 OUTLIER Glycine 0 N--CA 1.487 2.038 0 O-C-N 121.317 -0.864 . . . . 0.0 112.033 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.3 mp -68.46 -53.43 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 CA-C-N 117.926 0.863 . . . . 0.0 112.523 172.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.9 tp -67.6 -40.03 84.76 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mm -58.88 -39.24 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 164.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -59.27 -42.06 90.3 Favored 'General case' 0 CA--C 1.577 1.981 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 164.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -59.78 -45.15 93.17 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 164.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -83.4 68.53 9.75 Favored 'General case' 0 CA--C 1.575 1.925 0 O-C-N 121.081 -1.012 . . . . 0.0 113.528 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.6 ptt-85 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 123.677 1.703 . . . . 0.0 113.506 -178.097 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 CA--C 1.566 1.571 0 CA-C-O 121.374 0.606 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -64.13 -47.65 79.1 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -80.62 76.38 7.49 Favored 'General case' 0 CA--C 1.575 1.922 0 O-C-N 121.142 -0.974 . . . . 0.0 111.194 168.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.49 -59.36 2.8 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -161.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.3 t -62.61 -57.22 23.42 Favored Pre-proline 0 CA--C 1.58 2.1 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.05 -32.7 27.41 Favored 'Trans proline' 0 CA--C 1.568 2.217 0 CA-C-N 125.075 2.848 . . . . 0.0 117.904 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.35 -43.56 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 CA-C-N 120.781 1.628 . . . . 0.0 113.383 166.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.2 m -56.98 -43.96 82.22 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 167.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -57.68 -43.7 85.28 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 166.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.7 mt -59.91 -47.03 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 120.113 1.324 . . . . 0.0 113.543 169.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -56.15 -53.24 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 119.643 1.111 . . . . 0.0 113.489 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.32 -39.97 73.63 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 117.842 2.534 . . . . 0.0 117.842 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.7 m -63.45 -50.24 70.49 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 173.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.286 8.6 p -60.92 -43.51 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.267 29.9 m -64.63 -42.08 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 169.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.28 -47.27 89.1 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 168.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.67 -48.13 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-N 118.493 1.146 . . . . 0.0 113.836 168.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 27.6 tp -53.99 -47.4 71.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.9 mt -60.75 -41.86 96.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 166.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -62.62 -55.11 30.08 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.355 1.0 OUTLIER -64.28 -40.56 96.2 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 177.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.5 mt -73.61 -60.56 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 119.462 1.028 . . . . 0.0 112.232 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.3 mt -77.37 -47.86 18.78 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.51 -56.31 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 119.591 1.087 . . . . 0.0 112.446 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.9 t -75.86 -54.51 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-N 120.682 1.583 . . . . 0.0 114.08 -174.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.18 -46.08 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -175.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.276 30.6 m -100.24 -47.45 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 CA-C-N 121.311 1.869 . . . . 0.0 115.112 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.95 -59.85 7.56 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 118.005 1.962 . . . . 0.0 118.005 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.4 mt -63.46 -28.88 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 171.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.1 tp -51.17 -36.67 42.23 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 170.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.5 mm -59.59 -42.99 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -72.35 -39.56 68.01 Favored 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 167.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -64.59 -52.95 54.9 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -106.71 76.21 1.1 Allowed 'General case' 0 CA--C 1.569 1.687 0 CA-C-O 121.795 0.807 . . . . 0.0 109.899 170.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 124.827 2.251 . . . . 0.0 112.047 -170.286 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 CA--C 1.564 1.509 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -75.09 -63.16 1.33 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 119.565 1.075 . . . . 0.0 113.7 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -94.49 92.78 7.28 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 161.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.36 53.58 1.04 Allowed 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 -163.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 t -146.32 -64.52 0.02 OUTLIER Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 116.123 -1.894 . . . . 0.0 108.481 163.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -64.93 -43.39 12.11 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 CA-C-N 124.968 2.81 . . . . 0.0 117.03 169.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.84 -43.31 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-N 119.872 1.214 . . . . 0.0 113.406 171.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.7 m -57.34 -46.43 83.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 167.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -55.71 -47.79 76.27 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 168.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.21 -42.55 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 120.067 1.303 . . . . 0.0 114.163 174.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.1 -52.0 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 120.183 1.356 . . . . 0.0 113.306 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.11 72.5 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 168.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.5 m -63.14 -50.33 70.86 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.6 p -61.11 -43.29 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.267 30.5 m -64.77 -41.82 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 169.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.55 -47.17 91.47 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 168.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.58 -46.63 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 118.527 1.163 . . . . 0.0 114.003 168.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.92 -49.16 77.7 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 171.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.5 mt -60.44 -36.22 77.69 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.396 1.998 . . . . 0.0 116.396 167.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -60.41 -56.55 20.11 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 167.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.268 3.1 pp -63.21 -34.79 78.41 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.0 mt -75.03 -56.91 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 CA-C-N 119.664 1.12 . . . . 0.0 112.191 172.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.4 mt -93.01 -61.36 1.6 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -66.58 -38.64 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -173.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.33 -45.99 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.388 -1.445 . . . . 0.0 113.804 169.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.32 -63.85 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 120.269 1.395 . . . . 0.0 112.293 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.3 m -90.04 71.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-N 119.83 1.196 . . . . 0.0 112.07 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 169.8 -82.09 0.09 OUTLIER Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.112 -0.992 . . . . 0.0 113.72 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.9 mp -65.63 -53.56 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 CA-C-N 117.892 0.846 . . . . 0.0 112.393 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.1 tp -57.01 -34.98 68.7 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 170.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.9 mm -64.37 -50.64 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 119.327 0.967 . . . . 0.0 113.461 170.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -66.25 -29.52 69.78 Favored 'General case' 0 CA--C 1.579 2.078 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 170.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -61.1 -49.79 75.86 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 163.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -87.86 70.61 9.54 Favored 'General case' 0 CA--C 1.575 1.909 0 O-C-N 121.0 -1.063 . . . . 0.0 112.307 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 124.956 2.312 . . . . 0.0 110.303 -168.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.36 -61.19 1.87 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -83.39 71.1 10.28 Favored 'General case' 0 CA--C 1.575 1.915 0 O-C-N 120.977 -1.077 . . . . 0.0 112.059 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.85 -55.58 5.05 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -167.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.6 t -62.27 -52.72 64.47 Favored Pre-proline 0 CA--C 1.579 2.073 0 N-CA-C 117.361 2.356 . . . . 0.0 117.361 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.57 -33.16 29.46 Favored 'Trans proline' 0 CA--C 1.57 2.293 0 CA-C-N 125.437 2.977 . . . . 0.0 117.35 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.53 -45.56 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 120.323 1.419 . . . . 0.0 113.496 165.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 m -56.55 -44.78 81.26 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 168.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -57.44 -43.88 84.27 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 166.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.2 mt -59.94 -46.93 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 CA-C-N 120.078 1.308 . . . . 0.0 113.485 170.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.5 mt -56.16 -52.85 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-N 119.664 1.12 . . . . 0.0 113.548 171.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.26 76.24 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 169.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.9 m -63.68 -50.06 70.71 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 7.6 p -60.49 -42.97 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 175.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.268 31.1 m -64.34 -42.32 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 169.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.01 -46.9 90.97 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 167.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.5 t -60.28 -48.5 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 118.388 1.094 . . . . 0.0 113.851 168.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 tp -54.04 -47.95 71.04 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.5 mt -59.76 -40.51 88.42 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 166.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.8 -57.59 9.44 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.337 1.0 OUTLIER -64.65 -38.63 91.67 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.3 mt -75.73 -62.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 119.319 0.963 . . . . 0.0 111.783 175.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.0 mt -82.66 -44.48 15.68 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -172.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -74.59 -54.58 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 119.972 1.26 . . . . 0.0 112.3 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.78 -59.77 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 119.775 1.17 . . . . 0.0 113.144 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.261 93.0 t -76.0 -73.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 CA-C-N 120.411 1.46 . . . . 0.0 112.191 -173.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.28 27.2 m -84.08 60.04 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 CA-C-N 120.873 1.67 . . . . 0.0 113.461 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.93 -82.0 0.05 OUTLIER Glycine 0 N--CA 1.486 1.973 0 O-C-N 121.486 -0.759 . . . . 0.0 111.46 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.3 mt -70.92 -55.76 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 CA-C-N 117.923 0.861 . . . . 0.0 112.422 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.7 tp -62.39 -44.73 95.76 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.983 1.846 . . . . 0.0 115.983 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.251 38.7 mm -65.88 -34.12 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 171.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -63.05 -38.96 93.28 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 121.544 1.974 . . . . 0.0 116.028 164.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -67.2 -55.28 14.75 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 168.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.5 mtp-105 -135.09 99.73 4.36 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.268 1.027 . . . . 0.0 109.671 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 CA--C 1.564 1.494 0 CA-C-O 121.157 0.504 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -58.66 -44.52 90.2 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -71.73 -24.58 61.82 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.74 99.38 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.6 t -59.83 -54.28 57.11 Favored Pre-proline 0 CA--C 1.583 2.214 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 172.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -61.81 -38.18 61.57 Favored 'Trans proline' 0 CA--C 1.57 2.292 0 CA-C-N 125.318 2.935 . . . . 0.0 117.325 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.76 -45.29 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 119.863 1.21 . . . . 0.0 113.883 168.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.3 m -57.7 -44.49 85.92 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 168.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.06 -43.84 82.44 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 167.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.8 mt -60.32 -47.04 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-N 119.985 1.266 . . . . 0.0 113.503 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -56.13 -52.92 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 119.669 1.122 . . . . 0.0 113.533 171.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.6 -40.24 74.96 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 169.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.4 m -63.35 -50.26 70.68 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 173.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.3 p -60.72 -43.31 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.268 30.3 m -64.54 -42.21 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 169.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.32 -46.94 91.24 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 118.289 2.076 . . . . 0.0 118.289 168.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.34 -48.23 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 118.477 1.139 . . . . 0.0 113.809 168.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.4 tp -54.27 -48.0 71.68 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 171.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.7 mt -59.97 -40.58 89.59 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 166.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -63.17 -57.92 8.92 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.339 1.0 OUTLIER -64.51 -38.42 90.94 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt -75.81 -61.93 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-N 119.365 0.984 . . . . 0.0 111.874 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.8 mt -82.44 -45.9 14.19 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -172.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.03 -51.96 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 119.737 1.153 . . . . 0.0 112.696 177.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.47 -65.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-N 119.862 1.21 . . . . 0.0 112.353 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.256 71.7 t -67.86 -61.8 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-N 120.566 1.53 . . . . 0.0 113.874 -171.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.279 28.3 m -89.99 53.82 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 CA-C-N 120.933 1.697 . . . . 0.0 113.771 173.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.37 -93.18 0.09 OUTLIER Glycine 0 N--CA 1.487 2.046 0 O-C-N 120.936 -1.103 . . . . 0.0 112.533 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.277 1.8 mp -60.53 -45.17 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.8 tp -57.64 -34.1 68.99 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 166.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.8 mm -69.97 -44.95 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 120.092 1.314 . . . . 0.0 113.468 171.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -63.28 -42.32 99.1 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 115.508 1.669 . . . . 0.0 115.508 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -67.73 -36.3 80.33 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 169.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.2 mtp-105 -137.59 89.63 2.43 Favored 'General case' 0 CA--C 1.57 1.743 0 C-N-CA 124.464 1.106 . . . . 0.0 109.757 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 123.42 1.581 . . . . 0.0 114.478 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.582 2.205 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -60.91 -37.1 79.83 Favored 'Trans proline' 0 CA--C 1.569 2.23 0 CA-C-N 125.08 2.85 . . . . 0.0 117.601 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.9 -44.98 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-N 119.903 1.229 . . . . 0.0 113.949 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.2 m -58.29 -44.62 88.59 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -56.58 -43.93 80.51 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 167.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.1 mt -60.43 -47.26 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 119.916 1.234 . . . . 0.0 113.484 169.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.9 mt -56.13 -52.87 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 119.657 1.117 . . . . 0.0 113.594 171.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.28 74.35 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 168.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.5 m -63.33 -50.35 70.33 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.2 p -60.86 -42.95 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 175.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.266 30.0 m -64.89 -41.96 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 169.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.45 -46.98 92.36 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 118.238 2.055 . . . . 0.0 118.238 168.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.9 t -60.57 -46.68 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 168.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.0 tp -56.85 -47.95 79.2 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 170.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.4 mt -59.05 -42.31 89.97 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -60.2 -50.6 73.04 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.292 2.5 pp -62.62 -37.94 88.27 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 174.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.9 mt . . . . . 0 N--CA 1.5 2.046 0 CA-C-N 119.694 1.134 . . . . 0.0 111.969 172.529 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 CA--C 1.58 2.1 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.05 -32.7 27.41 Favored 'Trans proline' 0 CA--C 1.568 2.217 0 CA-C-N 125.075 2.848 . . . . 0.0 117.904 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.35 -43.56 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 CA-C-N 120.781 1.628 . . . . 0.0 113.383 166.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.2 m -56.98 -43.96 82.22 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 167.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -57.68 -43.7 85.28 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 166.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.7 mt -59.91 -47.03 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 120.113 1.324 . . . . 0.0 113.543 169.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -56.15 -53.24 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 119.643 1.111 . . . . 0.0 113.489 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.32 -39.97 73.63 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 117.842 2.534 . . . . 0.0 117.842 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.7 m -63.45 -50.24 70.49 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 173.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.286 8.6 p -60.92 -43.51 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.267 29.9 m -64.63 -42.08 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 169.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.28 -47.27 89.1 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 168.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.67 -48.13 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-N 118.493 1.146 . . . . 0.0 113.836 168.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 27.6 tp -53.99 -47.4 71.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.9 mt -60.75 -41.86 96.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 166.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -62.62 -55.11 30.08 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.355 1.0 OUTLIER -64.28 -40.56 96.2 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 177.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.5 mt . . . . . 0 N--CA 1.5 2.058 0 CA-C-N 119.462 1.028 . . . . 0.0 112.232 176.427 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 t . . . . . 0 CA--C 1.576 1.969 0 CA-C-O 116.123 -1.894 . . . . 0.0 108.481 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -64.93 -43.39 12.11 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 CA-C-N 124.968 2.81 . . . . 0.0 117.03 169.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.84 -43.31 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-N 119.872 1.214 . . . . 0.0 113.406 171.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.7 m -57.34 -46.43 83.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 167.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -55.71 -47.79 76.27 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 168.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.21 -42.55 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 120.067 1.303 . . . . 0.0 114.163 174.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.1 -52.0 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 120.183 1.356 . . . . 0.0 113.306 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.11 72.5 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 168.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.5 m -63.14 -50.33 70.86 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.6 p -61.11 -43.29 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.267 30.5 m -64.77 -41.82 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 169.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.55 -47.17 91.47 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 168.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.58 -46.63 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 118.527 1.163 . . . . 0.0 114.003 168.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.92 -49.16 77.7 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 171.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.5 mt -60.44 -36.22 77.69 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.396 1.998 . . . . 0.0 116.396 167.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -60.41 -56.55 20.11 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 167.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.268 3.1 pp -63.21 -34.79 78.41 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 N--CA 1.501 2.085 0 CA-C-N 119.664 1.12 . . . . 0.0 112.191 172.42 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.6 t . . . . . 0 CA--C 1.579 2.073 0 N-CA-C 117.361 2.356 . . . . 0.0 117.361 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.57 -33.16 29.46 Favored 'Trans proline' 0 CA--C 1.57 2.293 0 CA-C-N 125.437 2.977 . . . . 0.0 117.35 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.53 -45.56 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 120.323 1.419 . . . . 0.0 113.496 165.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 m -56.55 -44.78 81.26 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 168.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -57.44 -43.88 84.27 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 166.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.2 mt -59.94 -46.93 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 CA-C-N 120.078 1.308 . . . . 0.0 113.485 170.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.5 mt -56.16 -52.85 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-N 119.664 1.12 . . . . 0.0 113.548 171.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.26 76.24 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 169.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.9 m -63.68 -50.06 70.71 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 7.6 p -60.49 -42.97 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 175.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.268 31.1 m -64.34 -42.32 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 169.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.01 -46.9 90.97 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 167.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.5 t -60.28 -48.5 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 118.388 1.094 . . . . 0.0 113.851 168.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 tp -54.04 -47.95 71.04 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.5 mt -59.76 -40.51 88.42 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 166.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.8 -57.59 9.44 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.337 1.0 OUTLIER -64.65 -38.63 91.67 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.3 mt . . . . . 0 N--CA 1.498 1.94 0 CA-C-N 119.319 0.963 . . . . 0.0 111.783 175.984 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.6 t . . . . . 0 CA--C 1.583 2.214 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -61.81 -38.18 61.57 Favored 'Trans proline' 0 CA--C 1.57 2.292 0 CA-C-N 125.318 2.935 . . . . 0.0 117.325 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.76 -45.29 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 119.863 1.21 . . . . 0.0 113.883 168.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.3 m -57.7 -44.49 85.92 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 168.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.06 -43.84 82.44 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 167.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.8 mt -60.32 -47.04 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-N 119.985 1.266 . . . . 0.0 113.503 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -56.13 -52.92 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 119.669 1.122 . . . . 0.0 113.533 171.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.6 -40.24 74.96 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 169.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.4 m -63.35 -50.26 70.68 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 173.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.3 p -60.72 -43.31 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.268 30.3 m -64.54 -42.21 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 169.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.32 -46.94 91.24 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 118.289 2.076 . . . . 0.0 118.289 168.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.34 -48.23 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 118.477 1.139 . . . . 0.0 113.809 168.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.4 tp -54.27 -48.0 71.68 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 171.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.7 mt -59.97 -40.58 89.59 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 166.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -63.17 -57.92 8.92 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.339 1.0 OUTLIER -64.51 -38.42 90.94 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.498 1.971 0 CA-C-N 119.365 0.984 . . . . 0.0 111.874 175.858 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . 0.257 13.0 pt-20 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -62.0 -50.5 71.82 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -79.38 -40.0 31.2 Favored 'General case' 0 CA--C 1.574 1.877 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 165.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.02 92.44 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 118.268 2.692 . . . . 0.0 118.268 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -61.31 -56.55 32.86 Favored Pre-proline 0 CA--C 1.582 2.205 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 171.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -60.91 -37.1 79.83 Favored 'Trans proline' 0 CA--C 1.569 2.23 0 CA-C-N 125.08 2.85 . . . . 0.0 117.601 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.9 -44.98 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-N 119.903 1.229 . . . . 0.0 113.949 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.2 m -58.29 -44.62 88.59 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -56.58 -43.93 80.51 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 167.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.1 mt -60.43 -47.26 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 119.916 1.234 . . . . 0.0 113.484 169.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.9 mt -56.13 -52.87 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 119.657 1.117 . . . . 0.0 113.594 171.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.28 74.35 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 168.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.5 m -63.33 -50.35 70.33 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.2 p -60.86 -42.95 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 175.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.266 30.0 m -64.89 -41.96 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 169.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.45 -46.98 92.36 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 118.238 2.055 . . . . 0.0 118.238 168.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.9 t -60.57 -46.68 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 168.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.0 tp -56.85 -47.95 79.2 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 170.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.4 mt -59.05 -42.31 89.97 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -60.2 -50.6 73.04 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.292 2.5 pp -62.62 -37.94 88.27 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 174.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.9 mt -72.79 -60.61 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.694 1.134 . . . . 0.0 111.969 172.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 76.7 mt -78.9 -44.18 23.3 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -171.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.4 t -82.82 -54.81 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 119.553 1.07 . . . . 0.0 112.102 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.0 t -72.88 -56.74 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 120.773 -1.205 . . . . 0.0 113.28 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.254 90.0 t -71.75 -67.42 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-N 120.778 1.626 . . . . 0.0 112.446 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.295 29.3 m -85.11 58.35 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-N 120.964 1.711 . . . . 0.0 114.109 176.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -172.07 -78.79 0.05 OUTLIER Glycine 0 N--CA 1.487 2.038 0 O-C-N 121.317 -0.864 . . . . 0.0 112.033 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.3 mp -68.46 -53.43 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 CA-C-N 117.926 0.863 . . . . 0.0 112.523 172.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.9 tp -67.6 -40.03 84.76 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mm -58.88 -39.24 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 164.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -59.27 -42.06 90.3 Favored 'General case' 0 CA--C 1.577 1.981 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 164.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -59.78 -45.15 93.17 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 164.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -83.4 68.53 9.75 Favored 'General case' 0 CA--C 1.575 1.925 0 O-C-N 121.081 -1.012 . . . . 0.0 113.528 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.6 ptt-85 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 123.677 1.703 . . . . 0.0 113.506 -178.097 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 CA--C 1.566 1.571 0 CA-C-O 121.374 0.606 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -64.13 -47.65 79.1 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -80.62 76.38 7.49 Favored 'General case' 0 CA--C 1.575 1.922 0 O-C-N 121.142 -0.974 . . . . 0.0 111.194 168.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.49 -59.36 2.8 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -161.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.3 t -62.61 -57.22 23.42 Favored Pre-proline 0 CA--C 1.58 2.1 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.05 -32.7 27.41 Favored 'Trans proline' 0 CA--C 1.568 2.217 0 CA-C-N 125.075 2.848 . . . . 0.0 117.904 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.35 -43.56 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 CA-C-N 120.781 1.628 . . . . 0.0 113.383 166.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.2 m -56.98 -43.96 82.22 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 167.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -57.68 -43.7 85.28 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 166.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.7 mt -59.91 -47.03 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 120.113 1.324 . . . . 0.0 113.543 169.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -56.15 -53.24 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 119.643 1.111 . . . . 0.0 113.489 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.32 -39.97 73.63 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 117.842 2.534 . . . . 0.0 117.842 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.7 m -63.45 -50.24 70.49 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 173.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.286 8.6 p -60.92 -43.51 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.267 29.9 m -64.63 -42.08 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 169.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.28 -47.27 89.1 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 168.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.67 -48.13 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-N 118.493 1.146 . . . . 0.0 113.836 168.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 27.6 tp -53.99 -47.4 71.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.9 mt -60.75 -41.86 96.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 166.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -62.62 -55.11 30.08 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.355 1.0 OUTLIER -64.28 -40.56 96.2 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 177.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.5 mt -73.61 -60.56 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 119.462 1.028 . . . . 0.0 112.232 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.3 mt -77.37 -47.86 18.78 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.51 -56.31 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 119.591 1.087 . . . . 0.0 112.446 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.9 t -75.86 -54.51 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-N 120.682 1.583 . . . . 0.0 114.08 -174.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.18 -46.08 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -175.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.276 30.6 m -100.24 -47.45 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 CA-C-N 121.311 1.869 . . . . 0.0 115.112 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.95 -59.85 7.56 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 118.005 1.962 . . . . 0.0 118.005 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.4 mt -63.46 -28.88 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 171.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.1 tp -51.17 -36.67 42.23 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 170.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.5 mm -59.59 -42.99 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -72.35 -39.56 68.01 Favored 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 167.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -64.59 -52.95 54.9 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -106.71 76.21 1.1 Allowed 'General case' 0 CA--C 1.569 1.687 0 CA-C-O 121.795 0.807 . . . . 0.0 109.899 170.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 124.827 2.251 . . . . 0.0 112.047 -170.286 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 CA--C 1.564 1.509 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -75.09 -63.16 1.33 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 119.565 1.075 . . . . 0.0 113.7 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -94.49 92.78 7.28 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 161.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.36 53.58 1.04 Allowed 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 -163.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 t -146.32 -64.52 0.02 OUTLIER Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 116.123 -1.894 . . . . 0.0 108.481 163.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -64.93 -43.39 12.11 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 CA-C-N 124.968 2.81 . . . . 0.0 117.03 169.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.84 -43.31 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-N 119.872 1.214 . . . . 0.0 113.406 171.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.7 m -57.34 -46.43 83.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 167.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -55.71 -47.79 76.27 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 168.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.21 -42.55 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 120.067 1.303 . . . . 0.0 114.163 174.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.1 -52.0 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 120.183 1.356 . . . . 0.0 113.306 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.11 72.5 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 168.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.5 m -63.14 -50.33 70.86 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.6 p -61.11 -43.29 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.267 30.5 m -64.77 -41.82 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 169.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.55 -47.17 91.47 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 168.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.58 -46.63 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 118.527 1.163 . . . . 0.0 114.003 168.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.92 -49.16 77.7 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 171.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.5 mt -60.44 -36.22 77.69 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.396 1.998 . . . . 0.0 116.396 167.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -60.41 -56.55 20.11 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 167.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.268 3.1 pp -63.21 -34.79 78.41 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.0 mt -75.03 -56.91 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 CA-C-N 119.664 1.12 . . . . 0.0 112.191 172.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.4 mt -93.01 -61.36 1.6 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -66.58 -38.64 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -173.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.33 -45.99 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.388 -1.445 . . . . 0.0 113.804 169.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.32 -63.85 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 120.269 1.395 . . . . 0.0 112.293 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.3 m -90.04 71.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-N 119.83 1.196 . . . . 0.0 112.07 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 169.8 -82.09 0.09 OUTLIER Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.112 -0.992 . . . . 0.0 113.72 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.9 mp -65.63 -53.56 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 CA-C-N 117.892 0.846 . . . . 0.0 112.393 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.1 tp -57.01 -34.98 68.7 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 170.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.9 mm -64.37 -50.64 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 119.327 0.967 . . . . 0.0 113.461 170.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -66.25 -29.52 69.78 Favored 'General case' 0 CA--C 1.579 2.078 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 170.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -61.1 -49.79 75.86 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 163.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -87.86 70.61 9.54 Favored 'General case' 0 CA--C 1.575 1.909 0 O-C-N 121.0 -1.063 . . . . 0.0 112.307 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 124.956 2.312 . . . . 0.0 110.303 -168.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.36 -61.19 1.87 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -83.39 71.1 10.28 Favored 'General case' 0 CA--C 1.575 1.915 0 O-C-N 120.977 -1.077 . . . . 0.0 112.059 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.85 -55.58 5.05 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -167.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.6 t -62.27 -52.72 64.47 Favored Pre-proline 0 CA--C 1.579 2.073 0 N-CA-C 117.361 2.356 . . . . 0.0 117.361 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.57 -33.16 29.46 Favored 'Trans proline' 0 CA--C 1.57 2.293 0 CA-C-N 125.437 2.977 . . . . 0.0 117.35 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.53 -45.56 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 120.323 1.419 . . . . 0.0 113.496 165.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 m -56.55 -44.78 81.26 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 168.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -57.44 -43.88 84.27 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 166.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.2 mt -59.94 -46.93 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 CA-C-N 120.078 1.308 . . . . 0.0 113.485 170.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.5 mt -56.16 -52.85 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-N 119.664 1.12 . . . . 0.0 113.548 171.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.26 76.24 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 169.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.9 m -63.68 -50.06 70.71 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 7.6 p -60.49 -42.97 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 175.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.268 31.1 m -64.34 -42.32 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 169.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.01 -46.9 90.97 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 167.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.5 t -60.28 -48.5 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 118.388 1.094 . . . . 0.0 113.851 168.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 tp -54.04 -47.95 71.04 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.5 mt -59.76 -40.51 88.42 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 166.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.8 -57.59 9.44 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.337 1.0 OUTLIER -64.65 -38.63 91.67 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.3 mt -75.73 -62.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 119.319 0.963 . . . . 0.0 111.783 175.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.0 mt -82.66 -44.48 15.68 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -172.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -74.59 -54.58 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 119.972 1.26 . . . . 0.0 112.3 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.78 -59.77 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 119.775 1.17 . . . . 0.0 113.144 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.261 93.0 t -76.0 -73.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 CA-C-N 120.411 1.46 . . . . 0.0 112.191 -173.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.28 27.2 m -84.08 60.04 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 CA-C-N 120.873 1.67 . . . . 0.0 113.461 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.93 -82.0 0.05 OUTLIER Glycine 0 N--CA 1.486 1.973 0 O-C-N 121.486 -0.759 . . . . 0.0 111.46 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.3 mt -70.92 -55.76 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 CA-C-N 117.923 0.861 . . . . 0.0 112.422 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.7 tp -62.39 -44.73 95.76 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.983 1.846 . . . . 0.0 115.983 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.251 38.7 mm -65.88 -34.12 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 171.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -63.05 -38.96 93.28 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 121.544 1.974 . . . . 0.0 116.028 164.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -67.2 -55.28 14.75 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 168.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.5 mtp-105 -135.09 99.73 4.36 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.268 1.027 . . . . 0.0 109.671 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 CA--C 1.564 1.494 0 CA-C-O 121.157 0.504 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -58.66 -44.52 90.2 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -71.73 -24.58 61.82 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.74 99.38 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.6 t -59.83 -54.28 57.11 Favored Pre-proline 0 CA--C 1.583 2.214 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 172.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -61.81 -38.18 61.57 Favored 'Trans proline' 0 CA--C 1.57 2.292 0 CA-C-N 125.318 2.935 . . . . 0.0 117.325 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.76 -45.29 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 119.863 1.21 . . . . 0.0 113.883 168.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.3 m -57.7 -44.49 85.92 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 168.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.06 -43.84 82.44 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 167.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.8 mt -60.32 -47.04 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-N 119.985 1.266 . . . . 0.0 113.503 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -56.13 -52.92 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 119.669 1.122 . . . . 0.0 113.533 171.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.6 -40.24 74.96 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 169.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.4 m -63.35 -50.26 70.68 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 173.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.3 p -60.72 -43.31 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.268 30.3 m -64.54 -42.21 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 169.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.32 -46.94 91.24 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 118.289 2.076 . . . . 0.0 118.289 168.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.34 -48.23 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 118.477 1.139 . . . . 0.0 113.809 168.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.4 tp -54.27 -48.0 71.68 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 171.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.7 mt -59.97 -40.58 89.59 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 166.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -63.17 -57.92 8.92 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.339 1.0 OUTLIER -64.51 -38.42 90.94 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt -75.81 -61.93 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-N 119.365 0.984 . . . . 0.0 111.874 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.8 mt -82.44 -45.9 14.19 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -172.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.03 -51.96 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 119.737 1.153 . . . . 0.0 112.696 177.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.47 -65.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-N 119.862 1.21 . . . . 0.0 112.353 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.256 71.7 t -67.86 -61.8 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-N 120.566 1.53 . . . . 0.0 113.874 -171.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.279 28.3 m -89.99 53.82 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 CA-C-N 120.933 1.697 . . . . 0.0 113.771 173.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.37 -93.18 0.09 OUTLIER Glycine 0 N--CA 1.487 2.046 0 O-C-N 120.936 -1.103 . . . . 0.0 112.533 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.277 1.8 mp -60.53 -45.17 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.8 tp -57.64 -34.1 68.99 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 166.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.8 mm -69.97 -44.95 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 120.092 1.314 . . . . 0.0 113.468 171.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -63.28 -42.32 99.1 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 115.508 1.669 . . . . 0.0 115.508 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -67.73 -36.3 80.33 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 169.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.2 mtp-105 -137.59 89.63 2.43 Favored 'General case' 0 CA--C 1.57 1.743 0 C-N-CA 124.464 1.106 . . . . 0.0 109.757 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 123.42 1.581 . . . . 0.0 114.478 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.582 2.205 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -60.91 -37.1 79.83 Favored 'Trans proline' 0 CA--C 1.569 2.23 0 CA-C-N 125.08 2.85 . . . . 0.0 117.601 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.9 -44.98 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-N 119.903 1.229 . . . . 0.0 113.949 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.2 m -58.29 -44.62 88.59 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -56.58 -43.93 80.51 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 167.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.1 mt -60.43 -47.26 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 119.916 1.234 . . . . 0.0 113.484 169.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.9 mt -56.13 -52.87 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 119.657 1.117 . . . . 0.0 113.594 171.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.28 74.35 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 168.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.5 m -63.33 -50.35 70.33 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.2 p -60.86 -42.95 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 175.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.266 30.0 m -64.89 -41.96 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 169.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.45 -46.98 92.36 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 118.238 2.055 . . . . 0.0 118.238 168.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.9 t -60.57 -46.68 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 168.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.0 tp -56.85 -47.95 79.2 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 170.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.4 mt -59.05 -42.31 89.97 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -60.2 -50.6 73.04 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.292 2.5 pp -62.62 -37.94 88.27 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 174.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.9 mt . . . . . 0 N--CA 1.5 2.046 0 CA-C-N 119.694 1.134 . . . . 0.0 111.969 172.529 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 CA--C 1.58 2.1 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.05 -32.7 27.41 Favored 'Trans proline' 0 CA--C 1.568 2.217 0 CA-C-N 125.075 2.848 . . . . 0.0 117.904 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.35 -43.56 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 CA-C-N 120.781 1.628 . . . . 0.0 113.383 166.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.2 m -56.98 -43.96 82.22 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 167.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -57.68 -43.7 85.28 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 166.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.7 mt -59.91 -47.03 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 120.113 1.324 . . . . 0.0 113.543 169.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -56.15 -53.24 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 119.643 1.111 . . . . 0.0 113.489 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.32 -39.97 73.63 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 117.842 2.534 . . . . 0.0 117.842 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.7 m -63.45 -50.24 70.49 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 173.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.286 8.6 p -60.92 -43.51 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.267 29.9 m -64.63 -42.08 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 169.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.28 -47.27 89.1 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 168.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.67 -48.13 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-N 118.493 1.146 . . . . 0.0 113.836 168.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 27.6 tp -53.99 -47.4 71.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.9 mt -60.75 -41.86 96.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 166.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -62.62 -55.11 30.08 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.355 1.0 OUTLIER -64.28 -40.56 96.2 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 177.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.5 mt . . . . . 0 N--CA 1.5 2.058 0 CA-C-N 119.462 1.028 . . . . 0.0 112.232 176.427 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 t . . . . . 0 CA--C 1.576 1.969 0 CA-C-O 116.123 -1.894 . . . . 0.0 108.481 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -64.93 -43.39 12.11 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 CA-C-N 124.968 2.81 . . . . 0.0 117.03 169.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.84 -43.31 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-N 119.872 1.214 . . . . 0.0 113.406 171.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.7 m -57.34 -46.43 83.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 167.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -55.71 -47.79 76.27 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 168.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.21 -42.55 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 120.067 1.303 . . . . 0.0 114.163 174.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.1 -52.0 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 120.183 1.356 . . . . 0.0 113.306 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.11 72.5 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 168.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.5 m -63.14 -50.33 70.86 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.6 p -61.11 -43.29 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.267 30.5 m -64.77 -41.82 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 169.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.55 -47.17 91.47 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 168.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.58 -46.63 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 118.527 1.163 . . . . 0.0 114.003 168.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.92 -49.16 77.7 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 171.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.5 mt -60.44 -36.22 77.69 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.396 1.998 . . . . 0.0 116.396 167.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -60.41 -56.55 20.11 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 167.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.268 3.1 pp -63.21 -34.79 78.41 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 N--CA 1.501 2.085 0 CA-C-N 119.664 1.12 . . . . 0.0 112.191 172.42 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.6 t . . . . . 0 CA--C 1.579 2.073 0 N-CA-C 117.361 2.356 . . . . 0.0 117.361 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.57 -33.16 29.46 Favored 'Trans proline' 0 CA--C 1.57 2.293 0 CA-C-N 125.437 2.977 . . . . 0.0 117.35 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.53 -45.56 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 120.323 1.419 . . . . 0.0 113.496 165.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 m -56.55 -44.78 81.26 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 168.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -57.44 -43.88 84.27 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 166.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.2 mt -59.94 -46.93 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 CA-C-N 120.078 1.308 . . . . 0.0 113.485 170.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.5 mt -56.16 -52.85 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-N 119.664 1.12 . . . . 0.0 113.548 171.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.26 76.24 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 169.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.9 m -63.68 -50.06 70.71 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 7.6 p -60.49 -42.97 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 175.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.268 31.1 m -64.34 -42.32 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 169.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.01 -46.9 90.97 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 167.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.5 t -60.28 -48.5 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 118.388 1.094 . . . . 0.0 113.851 168.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 tp -54.04 -47.95 71.04 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.5 mt -59.76 -40.51 88.42 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 166.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.8 -57.59 9.44 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.337 1.0 OUTLIER -64.65 -38.63 91.67 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.3 mt . . . . . 0 N--CA 1.498 1.94 0 CA-C-N 119.319 0.963 . . . . 0.0 111.783 175.984 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.6 t . . . . . 0 CA--C 1.583 2.214 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -61.81 -38.18 61.57 Favored 'Trans proline' 0 CA--C 1.57 2.292 0 CA-C-N 125.318 2.935 . . . . 0.0 117.325 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.76 -45.29 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 119.863 1.21 . . . . 0.0 113.883 168.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.3 m -57.7 -44.49 85.92 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 168.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.06 -43.84 82.44 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 167.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.8 mt -60.32 -47.04 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-N 119.985 1.266 . . . . 0.0 113.503 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -56.13 -52.92 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 119.669 1.122 . . . . 0.0 113.533 171.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.6 -40.24 74.96 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 169.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.4 m -63.35 -50.26 70.68 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 173.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.3 p -60.72 -43.31 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.268 30.3 m -64.54 -42.21 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 169.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.32 -46.94 91.24 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 118.289 2.076 . . . . 0.0 118.289 168.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.34 -48.23 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 118.477 1.139 . . . . 0.0 113.809 168.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.4 tp -54.27 -48.0 71.68 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 171.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.7 mt -59.97 -40.58 89.59 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 166.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -63.17 -57.92 8.92 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.339 1.0 OUTLIER -64.51 -38.42 90.94 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.498 1.971 0 CA-C-N 119.365 0.984 . . . . 0.0 111.874 175.858 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . 0.257 13.0 pt-20 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -62.0 -50.5 71.82 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -79.38 -40.0 31.2 Favored 'General case' 0 CA--C 1.574 1.877 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 165.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.02 92.44 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 118.268 2.692 . . . . 0.0 118.268 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -61.31 -56.55 32.86 Favored Pre-proline 0 CA--C 1.582 2.205 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 171.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -60.91 -37.1 79.83 Favored 'Trans proline' 0 CA--C 1.569 2.23 0 CA-C-N 125.08 2.85 . . . . 0.0 117.601 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 93.1 t -60.9 -44.98 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-N 119.903 1.229 . . . . 0.0 113.949 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.2 m -58.29 -44.62 88.59 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -56.58 -43.93 80.51 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 167.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.1 mt -60.43 -47.26 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 119.916 1.234 . . . . 0.0 113.484 169.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.9 mt -56.13 -52.87 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 119.657 1.117 . . . . 0.0 113.594 171.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.28 74.35 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 168.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.5 m -63.33 -50.35 70.33 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 173.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.2 p -60.86 -42.95 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 175.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.266 30.0 m -64.89 -41.96 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 169.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.45 -46.98 92.36 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 118.238 2.055 . . . . 0.0 118.238 168.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.9 t -60.57 -46.68 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 168.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 33.0 tp -56.85 -47.95 79.2 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 170.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.4 mt -59.05 -42.31 89.97 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -60.2 -50.6 73.04 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 170.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.292 2.5 pp -62.62 -37.94 88.27 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 174.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.9 mt -72.79 -60.61 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 CA-C-N 119.694 1.134 . . . . 0.0 111.969 172.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 76.7 mt -78.9 -44.18 23.3 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -171.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.4 t -82.82 -54.81 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-N 119.553 1.07 . . . . 0.0 112.102 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.0 t -72.88 -56.74 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 120.773 -1.205 . . . . 0.0 113.28 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.254 90.0 t -71.75 -67.42 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-N 120.778 1.626 . . . . 0.0 112.446 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.295 29.3 m -85.11 58.35 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-N 120.964 1.711 . . . . 0.0 114.109 176.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -172.07 -78.79 0.05 OUTLIER Glycine 0 N--CA 1.487 2.038 0 O-C-N 121.317 -0.864 . . . . 0.0 112.033 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.3 mp -68.46 -53.43 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 CA-C-N 117.926 0.863 . . . . 0.0 112.523 172.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.9 tp -67.6 -40.03 84.76 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mm -58.88 -39.24 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 164.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -59.27 -42.06 90.3 Favored 'General case' 0 CA--C 1.577 1.981 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 164.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.6 ttm-85 -59.78 -45.15 93.17 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 164.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -83.4 68.53 9.75 Favored 'General case' 0 CA--C 1.575 1.925 0 O-C-N 121.081 -1.012 . . . . 0.0 113.528 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.6 ptt-85 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 123.677 1.703 . . . . 0.0 113.506 -178.097 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 CA--C 1.566 1.571 0 CA-C-O 121.374 0.606 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -64.13 -47.65 79.1 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -80.62 76.38 7.49 Favored 'General case' 0 CA--C 1.575 1.922 0 O-C-N 121.142 -0.974 . . . . 0.0 111.194 168.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.49 -59.36 2.8 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 -161.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.3 t -62.61 -57.22 23.42 Favored Pre-proline 0 CA--C 1.58 2.1 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.05 -32.7 27.41 Favored 'Trans proline' 0 CA--C 1.568 2.217 0 CA-C-N 125.075 2.848 . . . . 0.0 117.904 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.35 -43.56 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 CA-C-N 120.781 1.628 . . . . 0.0 113.383 166.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.2 m -56.98 -43.96 82.22 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 167.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -57.68 -43.7 85.28 Favored 'General case' 0 CA--C 1.575 1.942 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 166.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.7 mt -59.91 -47.03 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 120.113 1.324 . . . . 0.0 113.543 169.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -56.15 -53.24 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 119.643 1.111 . . . . 0.0 113.489 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.32 -39.97 73.63 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 117.842 2.534 . . . . 0.0 117.842 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.7 m -63.45 -50.24 70.49 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 173.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.286 8.6 p -60.92 -43.51 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.267 29.9 m -64.63 -42.08 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 169.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.28 -47.27 89.1 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 118.302 2.081 . . . . 0.0 118.302 168.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.7 t -60.67 -48.13 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-N 118.493 1.146 . . . . 0.0 113.836 168.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 27.6 tp -53.99 -47.4 71.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.9 mt -60.75 -41.86 96.27 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 166.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -62.62 -55.11 30.08 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.355 1.0 OUTLIER -64.28 -40.56 96.2 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 177.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.5 mt -73.61 -60.56 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-N 119.462 1.028 . . . . 0.0 112.232 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.3 mt -77.37 -47.86 18.78 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.51 -56.31 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 119.591 1.087 . . . . 0.0 112.446 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.9 t -75.86 -54.51 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-N 120.682 1.583 . . . . 0.0 114.08 -174.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -71.18 -46.08 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -175.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.276 30.6 m -100.24 -47.45 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 CA-C-N 121.311 1.869 . . . . 0.0 115.112 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.95 -59.85 7.56 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 118.005 1.962 . . . . 0.0 118.005 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.4 mt -63.46 -28.88 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 171.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.1 tp -51.17 -36.67 42.23 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 117.872 2.545 . . . . 0.0 117.872 170.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.5 mm -59.59 -42.99 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -72.35 -39.56 68.01 Favored 'General case' 0 CA--C 1.579 2.093 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 167.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -64.59 -52.95 54.9 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -106.71 76.21 1.1 Allowed 'General case' 0 CA--C 1.569 1.687 0 CA-C-O 121.795 0.807 . . . . 0.0 109.899 170.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 124.827 2.251 . . . . 0.0 112.047 -170.286 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 CA--C 1.564 1.509 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -75.09 -63.16 1.33 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 119.565 1.075 . . . . 0.0 113.7 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -94.49 92.78 7.28 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 161.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.36 53.58 1.04 Allowed 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 -163.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 t -146.32 -64.52 0.02 OUTLIER Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 116.123 -1.894 . . . . 0.0 108.481 163.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -64.93 -43.39 12.11 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 CA-C-N 124.968 2.81 . . . . 0.0 117.03 169.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.84 -43.31 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-N 119.872 1.214 . . . . 0.0 113.406 171.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.7 m -57.34 -46.43 83.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 167.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -55.71 -47.79 76.27 Favored 'General case' 0 CA--C 1.574 1.888 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 168.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.21 -42.55 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 120.067 1.303 . . . . 0.0 114.163 174.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.1 -52.0 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.301 0 CA-C-N 120.183 1.356 . . . . 0.0 113.306 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.11 72.5 Favored 'General case' 0 CA--C 1.575 1.934 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 168.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.5 m -63.14 -50.33 70.86 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.6 p -61.11 -43.29 95.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 175.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.267 30.5 m -64.77 -41.82 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 169.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.55 -47.17 91.47 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 118.22 2.048 . . . . 0.0 118.22 168.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.58 -46.63 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 118.527 1.163 . . . . 0.0 114.003 168.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.92 -49.16 77.7 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 171.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.5 mt -60.44 -36.22 77.69 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.396 1.998 . . . . 0.0 116.396 167.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -60.41 -56.55 20.11 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 167.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.268 3.1 pp -63.21 -34.79 78.41 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 117.687 2.477 . . . . 0.0 117.687 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.0 mt -75.03 -56.91 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 CA-C-N 119.664 1.12 . . . . 0.0 112.191 172.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.4 mt -93.01 -61.36 1.6 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -66.58 -38.64 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -173.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.33 -45.99 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.388 -1.445 . . . . 0.0 113.804 169.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.32 -63.85 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-N 120.269 1.395 . . . . 0.0 112.293 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.3 m -90.04 71.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-N 119.83 1.196 . . . . 0.0 112.07 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 169.8 -82.09 0.09 OUTLIER Glycine 0 N--CA 1.489 2.219 0 O-C-N 121.112 -0.992 . . . . 0.0 113.72 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.9 mp -65.63 -53.56 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 CA-C-N 117.892 0.846 . . . . 0.0 112.393 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.1 tp -57.01 -34.98 68.7 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 170.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.9 mm -64.37 -50.64 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 119.327 0.967 . . . . 0.0 113.461 170.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -66.25 -29.52 69.78 Favored 'General case' 0 CA--C 1.579 2.078 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 170.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -61.1 -49.79 75.86 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 163.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -87.86 70.61 9.54 Favored 'General case' 0 CA--C 1.575 1.909 0 O-C-N 121.0 -1.063 . . . . 0.0 112.307 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 124.956 2.312 . . . . 0.0 110.303 -168.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.36 -61.19 1.87 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -83.39 71.1 10.28 Favored 'General case' 0 CA--C 1.575 1.915 0 O-C-N 120.977 -1.077 . . . . 0.0 112.059 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.85 -55.58 5.05 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 -167.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.6 t -62.27 -52.72 64.47 Favored Pre-proline 0 CA--C 1.579 2.073 0 N-CA-C 117.361 2.356 . . . . 0.0 117.361 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.57 -33.16 29.46 Favored 'Trans proline' 0 CA--C 1.57 2.293 0 CA-C-N 125.437 2.977 . . . . 0.0 117.35 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.53 -45.56 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 120.323 1.419 . . . . 0.0 113.496 165.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 m -56.55 -44.78 81.26 Favored 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 168.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -57.44 -43.88 84.27 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 166.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.2 mt -59.94 -46.93 93.41 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 CA-C-N 120.078 1.308 . . . . 0.0 113.485 170.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.5 mt -56.16 -52.85 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-N 119.664 1.12 . . . . 0.0 113.548 171.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.26 76.24 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 169.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.9 m -63.68 -50.06 70.71 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 7.6 p -60.49 -42.97 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 175.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.268 31.1 m -64.34 -42.32 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 169.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.01 -46.9 90.97 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 167.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.5 t -60.28 -48.5 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 118.388 1.094 . . . . 0.0 113.851 168.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 tp -54.04 -47.95 71.04 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.5 mt -59.76 -40.51 88.42 Favored 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 166.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.8 -57.59 9.44 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 175.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.337 1.0 OUTLIER -64.65 -38.63 91.67 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.3 mt -75.73 -62.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 119.319 0.963 . . . . 0.0 111.783 175.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.0 mt -82.66 -44.48 15.68 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -172.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.6 t -74.59 -54.58 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-N 119.972 1.26 . . . . 0.0 112.3 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.78 -59.77 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 119.775 1.17 . . . . 0.0 113.144 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.261 93.0 t -76.0 -73.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 CA-C-N 120.411 1.46 . . . . 0.0 112.191 -173.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.28 27.2 m -84.08 60.04 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.426 0 CA-C-N 120.873 1.67 . . . . 0.0 113.461 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.93 -82.0 0.05 OUTLIER Glycine 0 N--CA 1.486 1.973 0 O-C-N 121.486 -0.759 . . . . 0.0 111.46 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.3 mt -70.92 -55.76 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 CA-C-N 117.923 0.861 . . . . 0.0 112.422 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.7 tp -62.39 -44.73 95.76 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.983 1.846 . . . . 0.0 115.983 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.251 38.7 mm -65.88 -34.12 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 171.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -63.05 -38.96 93.28 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 121.544 1.974 . . . . 0.0 116.028 164.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -67.2 -55.28 14.75 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 168.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.5 mtp-105 -135.09 99.73 4.36 Favored 'General case' 0 CA--C 1.567 1.616 0 C-N-CA 124.268 1.027 . . . . 0.0 109.671 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 CA--C 1.564 1.494 0 CA-C-O 121.157 0.504 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -58.66 -44.52 90.2 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -71.73 -24.58 61.82 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.74 99.38 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.6 t -59.83 -54.28 57.11 Favored Pre-proline 0 CA--C 1.583 2.214 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 172.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -61.81 -38.18 61.57 Favored 'Trans proline' 0 CA--C 1.57 2.292 0 CA-C-N 125.318 2.935 . . . . 0.0 117.325 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.76 -45.29 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 119.863 1.21 . . . . 0.0 113.883 168.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.3 m -57.7 -44.49 85.92 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 168.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.06 -43.84 82.44 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 167.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.8 mt -60.32 -47.04 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-N 119.985 1.266 . . . . 0.0 113.503 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.6 mt -56.13 -52.92 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 119.669 1.122 . . . . 0.0 113.533 171.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.6 -40.24 74.96 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 169.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.4 m -63.35 -50.26 70.68 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 173.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.284 8.3 p -60.72 -43.31 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.268 30.3 m -64.54 -42.21 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 169.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.32 -46.94 91.24 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 118.289 2.076 . . . . 0.0 118.289 168.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.34 -48.23 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 118.477 1.139 . . . . 0.0 113.809 168.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.4 tp -54.27 -48.0 71.68 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 116.504 2.038 . . . . 0.0 116.504 171.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 68.7 mt -59.97 -40.58 89.59 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 166.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -63.17 -57.92 8.92 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . 0.339 1.0 OUTLIER -64.51 -38.42 90.94 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt -75.81 -61.93 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-N 119.365 0.984 . . . . 0.0 111.874 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.8 mt -82.44 -45.9 14.19 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -172.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.4 t -74.03 -51.96 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 CA-C-N 119.737 1.153 . . . . 0.0 112.696 177.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.47 -65.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-N 119.862 1.21 . . . . 0.0 112.353 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.256 71.7 t -67.86 -61.8 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-N 120.566 1.53 . . . . 0.0 113.874 -171.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.279 28.3 m -89.99 53.82 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 CA-C-N 120.933 1.697 . . . . 0.0 113.771 173.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.37 -93.18 0.09 OUTLIER Glycine 0 N--CA 1.487 2.046 0 O-C-N 120.936 -1.103 . . . . 0.0 112.533 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.277 1.8 mp -60.53 -45.17 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 32.8 tp -57.64 -34.1 68.99 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 116.792 2.145 . . . . 0.0 116.792 166.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.8 mm -69.97 -44.95 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 120.092 1.314 . . . . 0.0 113.468 171.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -63.28 -42.32 99.1 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 115.508 1.669 . . . . 0.0 115.508 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -67.73 -36.3 80.33 Favored 'General case' 0 CA--C 1.576 1.968 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 169.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.2 mtp-105 -137.59 89.63 2.43 Favored 'General case' 0 CA--C 1.57 1.743 0 C-N-CA 124.464 1.106 . . . . 0.0 109.757 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 123.42 1.581 . . . . 0.0 114.478 178.918 . . . . . . . . 1 1 . 1 stop_ save_